Tag: Millions

Categories
Politics

Unemployment Advantages to Hundreds of thousands Are About to Finish

Unemployment Benefits to Millions Are About to End

“You put 10, 15, 20 years into a career and then to suddenly not be able to go see a dentist anymore, it feels like something’s wrong there,” she said. “I think I’m still grieving the loss of my opportunity of being middle class, because that’s gone again.”

Regular unemployment benefits, without the $300 add-on, replace only a fraction of workers’ lost wages. In Pennsylvania, the maximum benefit is $580 a week, the equivalent of about $30,000 a year. In some Southern states, the maximum benefit is less than $300 a week.

Still, decades of economic research have shown that unemployment benefits are at least a bit of a disincentive to seeking work. When the economy is weak, that negative consequence is offset by the positive impact the benefits have on workers, but many economists argue that it makes sense to ramp down benefits as the economy improves.

Cutting off benefits for millions of people all at once, however, is another matter.

“Losing a job is something that we know from research is one of the most damaging things to your financial and personal well-being over the long run,” said Andrew Stettner, a senior fellow at the Century Foundation. “We’ve avoided those kinds of long-term impacts to a large part during the pandemic because we’ve been aggressive with our forms of support. Now we’re pulling it back, we’re putting people at risk.”

Ms. Harrison, despite her master’s degree, has already lost her job twice since the pandemic began. She was furloughed from her human resources job early on. She eventually found work helping to run a Covid-testing business, but was laid off again in March as the pandemic began to ebb. Now she spends her days scouring job boards and sending applications.

“It’s going to end,” she said of the unemployment benefits. “You know it’s going to end. So you can’t just sit around and twiddle your thumbs.”

Her husband has diabetes and high blood pressure, and they live with her mother, so Ms. Harrison, 47, is reluctant to return to in-person work until the pandemic is under control. Despite having a master’s degree and senior-level experience, she is applying for positions as a receptionist or an administrative assistant — jobs she last did decades ago.

Categories
Politics

Thousands and thousands of People Might Be Eligible for Covid Vaccine Booster

Millions of Americans Could Be Eligible for Covid Vaccine Booster

More than five million Americans could be eligible for a booster dose of the Covid-19 vaccine by the end of September as part of the Biden administration’s plan to combat the Delta variant of the coronavirus through additional doses eight months after the initial vaccinations.

However, the plan depends on several crucial steps that will take place over the coming weeks. Most importantly, the Food and Drug Administration would have to decide that third vaccinations would be safe and effective for Pfizer-BioNTech and Moderna, the two vaccines that were first introduced and most widely used.

Pfizer is further advanced in submitting data to the FDA that it says supports the use of boosters. Moderna and the National Institutes of Health are still investigating whether a half or a full dose for a third shot would work better, but are expecting results soon. Moderna CEO Stephane Bancel said the company plans to file its data with the FDA in September.

Government officials are due to announce the strategy at a White House briefing on Wednesday. Nursing home residents, nurses, and rescue workers would likely come first, as with the first few shots. Other older people would follow next, followed by the rest of the general population.

Officials envision giving people the same vaccine they were originally given and using pharmacies as key distribution points.

Administration officials discourage people from checking for booster doses on their own, noting that the FDA has yet to decide about their safety and effectiveness. They hope to distribute extra shots in an orderly manner so that people can get a booster shot when advised, and not just based on their own fears.

Dr. Danny Avula, the vaccine coordinator for the state of Virginia, said his state already has thousands of vaccine providers and can likely manage booster vaccinations without major changes. “What caused so much of the urgency and frenzy of January through April was the delivery bottleneck,” he said.

Now the government has more than 100 million doses in stock that could be used for boosters, along with tens of millions more doses that have already been shipped to pharmacies and other places. Even more supplies are to be delivered in autumn.

In interviews on Tuesday, hospital officials and doctors generally supported calls for a booster vaccination.

“I think we’re running out of second chances,” said Dr. Matthew Harris, the medical director of the coronavirus vaccination program at Northwell Health, New York’s largest hospital system. “What keeps me up at night is the inevitability of a variant that doesn’t respond to the vaccine. So if we have that head start, I fully support it.”

Understand the state of vaccination and masking requirements in the United States

    • Mask rules. The Centers for Disease Control and Prevention in July recommended that all Americans, regardless of vaccination status, wear masks in public places indoors in areas with outbreaks, reversing the guidelines offered in May. See where the CDC guidelines would apply and where states have implemented their own mask guidelines. The battle over masks is controversial in some states, with some local leaders defying state bans.
    • Vaccination regulations. . . and B.Factories. Private companies are increasingly demanding corona vaccines for employees with different approaches. Such mandates are legally permissible and have been confirmed in legal challenges.
    • College and Universities. More than 400 colleges and universities require a vaccination against Covid-19. Almost all of them are in states that voted for President Biden.
    • schools. On August 11, California announced that teachers and staff at both public and private schools would have to get vaccinated or have regular tests, the first state in the nation to do so. A survey published in August found that many American parents of school-age children are against mandatory vaccines for students, but are more supportive of masking requirements for students, teachers and staff who do not have a vaccination.
    • Hospitals and medical centers. Many hospitals and large health systems require their employees to receive a Covid-19 vaccine, due to rising case numbers due to the Delta variant and persistently low vaccination rates in their communities, even within their workforce.
    • new York. On August 3, New York City Mayor Bill de Blasio announced that workers and customers will be required to provide proof of vaccination when dining indoors, gyms, performances, and other indoor situations. City hospital staff must also be vaccinated or have weekly tests. Similar rules apply to employees in New York State.
    • At the federal level. The Pentagon announced that it would make coronavirus vaccinations compulsory for the country’s 1.3 million active soldiers “by mid-September at the latest. President Biden announced that all civil federal employees would need to be vaccinated against the coronavirus or undergo regular tests, social distancing, mask requirements and travel restrictions.

Federal officials envision offering additional vaccinations to recipients of Johnson & Johnson’s single-dose vaccine, as well as those who received Moderna or Pfizer. But the government didn’t start offering this vaccine until March, and only 14 million people have received it. For comparison: 155 million people were fully vaccinated with Pfizer or Moderna.

Data from a Johnson & Johnson clinical trial in which participants were given two doses is likely to be submitted to the FDA later this month and is intended to guide the government’s recommendation on the vaccine.

At the Wednesday briefing, administration officials plan to point out that a booster strategy is essential, even if it needs to be changed as more data comes in. They are expected to provide data showing the overall effectiveness of the vaccine against viral infections is declining, although unvaccinated people still make up the vast majority of people who become seriously ill or hospitalized due to Covid.

The government fears that without boosters, more vaccinated people could get serious Covid disease in the coming months, as there is a double trend: the stronger effect of the delta variant and the decreasing protection of the vaccines.

Data from the Israeli Ministry of Health are seen as a warning sign. It suggests that protection from viral infections fell in June and July relative to the time since a person was vaccinated. According to a data set, the effectiveness of the Pfizer vaccine against serious illnesses in people 65 and over who were vaccinated in January fell to 55 percent. But the margin of error was wide and experts said other data appeared less worrying.

Categories
Health

Respiration Machine Recall Over Potential Most cancers Threat Leaves Thousands and thousands Scrambling for Substitutes

Breathing Machine Recall Over Possible Cancer Risk Leaves Millions Scrambling for Substitutes

Jayme Rubenstein, a spokesperson for ResMed, said the company is prioritizing the manufacture of devices for patients with immediate ventilation needs, including Covid patients, followed by machines for those with central and obstructive sleep apnea.

In a survey of home medical device providers conducted in April 2020, more than half reported interruptions in the supply chain for CPAP devices and 62 percent reported delays of up to 60 days. The Philips recall “certainly exacerbated the situation,” said Thomas Ryan, chairman of the American Association for Homecare, which commissioned the study and represents the suppliers. (Philips is on his board.)

“Given the shortage of materials to make these devices, such as resins and computer chip modules, and transportation bottlenecks, I expect supply will continue to lag behind demand through 2022,” he said. “It will be a crisis”

Amy Sloane, who learned she had sleep apnea in 2017, began using a DreamStation BiPAP Auto SV device the following year. Overall, she said, her sleep improved. However, after reading about the recall, she became concerned to learn that the sonic cleaning device she was using could break the foam barrier.

“Even more annoying,” she said, “when I manually wiped my DreamStation water tank, there were black particles on the wipe.”

Ms. Sloane, 57, a Baltimore-based attorney, early registered her device with Philips for recall. But she said the company’s only response was to tell her to consult her doctor, who advised her to stop using it immediately. Within a few days, her doctor was able to prescribe a self-adjusting CPAP device from another manufacturer.

As of June, around 40 lawsuits have been filed against Philips on behalf of patients in more than 20 states. Steven Bloch, an attorney for Silver Golub & Teitell in Stamford, Connecticut, said his law firm has filed four lawsuits in Massachusetts, where Philips’ US headquarters are located.

Categories
Health

Tens of millions of Brits set for self-isolation as Covid restrictions ease

Millions of Brits set for self-isolation as Covid restrictions ease

Selective focus. Concept photo.

Oleksandr Siedov | iStock editorial team | Getty Images

LONDON – More than 500,000 people in the UK were asked to self-isolate last week by the government-backed Covid-19 Test and Trace app, with similar numbers expected in the coming weeks.

In the week leading up to July 7, the app alerted 520,194 people in England that they were in close contact with someone who tested positive for coronavirus and had to self-isolate.

A BBC analysis last week found that up to 4.5 million people in the UK could be instructed to self-isolate by the test and trace system between mid-July and the policy change on August 16.

A study published in the British Medical Journal in late June looked at the interactions of 5,802 people over 14 days and found that the average participant had 59 interactions that could be defined as close contact. The study found that for each infected person, an average of 36 close contacts could be identified and contacted, which could mean millions are currently being asked to self-isolate.

Earlier this week, UK media reported that Covid app users were “pinged” and asked to self-isolate when their neighbors contracted the virus, using the technology underlying the app’s testing and tracking system, ” close contact ”with positive cases through the walls recognizes their homes.

Currently, anyone in the UK who has had close contact tested positive for Covid must self-isolate at home for 10 days. People can be contacted by the NHS Test and Trace System by phone, email or SMS, or via a notification in the app.

“Close contact” is defined in the UK as 15 minutes or more within two meters of an infected person.

British Health Minister Sajid Javid recently announced that from August 16, people fully vaccinated against Covid will no longer have to self-isolate if close contact tests positive for the coronavirus. The amendment to the directive would also apply to children under the age of 18.

Employee Absence Concerns

England will lift almost all remaining Covid restrictions on Monday in what will be an “irreversible” move, according to Prime Minister Boris Johnson.

Currently, however, the country is seeing a surge in new cases of the virus linked to the highly transmissible Delta variant.

There were 48,553 new cases of the virus in the UK on Thursday, bringing the total number of confirmed cases in the country since the pandemic started to 5,281,098.

Rising case numbers have raised concerns among industry leaders that the contact tracing system could lead to staff shortages.

Karan Bilimoria, president of the Confederation of British Industry – which represents 190,000 companies – said in a statement Thursday that the government should present the rule changes on self-isolation.

“Infection rates can rise rapidly, but it is clear that the testing and tracking system needs an overhaul as over two-thirds of the adult population are now fully vaccinated,” he said.

“As more and more companies prepare to open their doors on Monday, the shortage of staff is acutely felt in all sectors and in all lines of business, especially in our troubled hospitality and leisure sectors.”

Nick Allen, CEO of the British Meat Processors Association, told the BBC on Friday that some organizations could potentially be forced to close production lines, with up to one in ten meat production workers being told by the app to isolate themselves.

Meanwhile, it was reported on Monday that passengers flying from Terminal 5 at London’s Heathrow Airport faced disruption after a number of NHS Test and Trace staff were instructed to isolate themselves.

Up to 900 workers – more than one in ten employees – at Nissan’s manufacturing facility in Sunderland, England, are currently absent after being “peded” by the app, the BBC reported on Thursday.

Delete the app

A survey by Savanta ComRes for the Guardian newspaper published Tuesday found that more than one in three adults ages 18 to 34 had already deleted the NHS app. According to the survey, roughly one in five adults of all ages said they intend to delete it within a week.

Government officials and health officials have urged the UK public not to delete the app.

A spokesman for the UK Health and Welfare Department emailed CNBC on Friday that the NHS Covid app prevented an estimated 600,000 infections and 8,000 deaths between September and December.

“The app does exactly what it was designed to do – it informs close contacts of someone who tests positive for Covid-19 that they are at risk and advises them to isolate themselves,” they said.

“As cases continue to rise, it is important that people are aware of their personal risk so that they can make informed decisions about their behavior to protect those around them.”

Jenny Harries, chief executive of the UK health authority, said during a hearing of evidence in Parliament last week that work was being done to “tune” the app to take into account vaccination status.

“Right now, it’s important to remind people of the importance of keeping the app running,” she said.

The NHS app, which has been downloaded more than 26 million times, is not mandatory and there is no legal obligation for users to isolate themselves if they are “pinged”.

Categories
Health

Hundreds of thousands might be affected by lengthy Covid, British research suggests

Symptoms, spread and what to look out for

Healthcare workers in North Memorial’s 2019s South Six and South Seven Intensive Care Units treated patients critically ill with COVID-19 on Monday, Dec. 7, 2020 at North Memorial Health Hospital in Robbinsdale, Minn.

Aaron Lavinsky | Star Tribune via Getty Images

A study in England looking at persistent Covid-19 symptoms suggests that around 2 million people in the country may have had the condition known as “long Covid.”

The study, part of Imperial College London’s REACT research which is tracking the virus in England, saw 508,707 people across the country of roughly 56 million asked whether they’d had Covid (confirmed or suspected), and asked about the presence and duration of 29 different symptoms linked to the virus.

Among the 76,155 participants that said they had experienced a symptomatic Covid infection, 37.7% said they experienced at least one symptom lasting 12 weeks or more, while almost 15% of people said they had experienced three or more symptoms lasting 12 weeks or more.

The symptoms of long Covid can vary, with people reporting ongoing fatigue, shortness of breath, memory loss or problems with concentration (dubbed “brain fog”), insomnia, chest pain or dizziness, as well as other symptoms. But it is still poorly understood and scientists don’t yet know why some people continue to have symptoms post-Covid, and others none.

“In this large community-based study of symptoms following Covid-19 among adults aged 18 years and above in England, participants reported high prevalence of persistent symptoms lasting 12 weeks or more,” the researchers at Imperial noted of their latest study.

Extrapolating the findings in the study to the wider Covid backdrop in England, where there have been 4.07 million Covid cases confirmed to date, the study could mean that over 2 million adults who have had the virus in England may have experienced some form of long Covid.

“Estimates ranged from 5.8% of the population experiencing one or more persistent symptoms post-Covid-19 (corresponding to over 2 million adults in England), to 2.2% for three or more persistent symptoms (just under a million adults in England),” the researchers noted.

They said that their estimates of the proportion of people with persistent Covid symptoms were higher than in many other studies, although previous estimates have varied widely.

“Our comparatively high estimate, at 37.7% of people with Covid-19 experiencing one or more symptoms at 12 weeks, may partly reflect the large list of symptoms we surveyed, many of which are common and not specific to Covid-19. However, we asked participants only about symptoms that they related to a confirmed or suspected episode of Covid-19, and not to symptoms more generally.”

Scientists are still investigating long Covid, and experts have urged the British government to address its public health implications; the National Health Service has opened long Covid assessment centers, for example.

“A substantial proportion of people with symptomatic Covid-19 go on to have persistent symptoms for 12 weeks or more, which is age-dependent. Clinicians need to be aware of the differing manifestations of Long Covid which may require tailored therapeutic approaches,” researchers at Imperial said.

The survey data was collected between Sept. 15 last year and Feb. 8 and the study is a preprint, and has not yet been peer-reviewed or published in a journal. 

Categories
Health

Biden to Ship Thousands and thousands of Pfizer Vaccine Doses to 100 Nations

Biden to Send Millions of Pfizer Vaccine Doses to 100 Countries

WASHINGTON – President Biden, under pressure to aggressively address the global coronavirus vaccine shortage, will announce Thursday that his government will buy 500 million doses of the Pfizer BioNTech vaccine and deliver them to about 100 countries next year The donation will be made by people familiar with the plan.

The White House reached the deal just in time for Mr Biden’s eight-day tour of Europe, which will be his first opportunity to assert the United States as world leader and to re-establish ties that have been badly frayed by President Donald J. Trump.

“We have to end Covid-19, not just at home we do, but everywhere,” Biden told American troops after landing at RAF Mildenhall in Suffolk, England. “There is no wall high enough to protect us from this pandemic or the next biological threat we face, and there will be others. It requires coordinated multilateral action. “

People familiar with the Pfizer deal said the United States would pay for the cans at a “not for profit” price. The first 200 million cans will be distributed by the end of this year, followed by 300 million by next June, they said. The doses will be distributed through Covax, the international vaccine exchange initiative.

Mr Biden is in Europe for a week to attend the NATO and Group of 7 summits and to meet with President Vladimir V. Putin in Geneva. He will likely use the trip to urge other nations to step up vaccine distribution.

In a statement Wednesday, Jeffrey D. Zients, White House official in charge of developing a global vaccination strategy, said Biden will “bring the world’s democracies together to resolve this global crisis, with America leading the way, the vaccine arsenal that will be of vital importance in our global fight against Covid-19. “

The White House is trying to highlight its success in fighting the pandemic – especially its vaccination campaign – and using that success as a diplomatic tool, especially as China and Russia are trying to do the same. Mr Biden has insisted that unlike China and Russia, who share their vaccines with dozens of countries, the United States will not attempt to extort promises from countries that receive US-made vaccines.

The 500 million doses are still well below the 11 billion the World Health Organization estimates to vaccinate the world, but well above what the United States has promised so far. Other nations have asked the United States to give up some of its ample vaccine supplies. In some African countries, less than 1 percent of people are fully vaccinated compared to 42 percent in the United States and the United Kingdom.

Global health advocates welcomed the news but reiterated their stance that it is not enough for the United States to simply give away vaccines. They say the Biden government needs to create the conditions for other countries to manufacture vaccines themselves, including transferring technology to make the cans.

“The world desperately needs new productions to produce billions more doses within a year, not just pledges to buy planned inadequate supplies,” Peter Maybarduk, director of the Citizens’ Access to Medicines Program, said in a Explanation. He added, “We have not yet seen a US government or G7 plan with the ambition or urgency to add billions more doses and end the pandemic.”

The Pfizer deal has the potential to open the door to similar agreements with other vaccine makers, including Moderna, whose vaccine, unlike Pfizer’s, was developed with US taxpayers’ money. In addition, the Biden government has negotiated a deal whereby Merck will help manufacture Johnson & Johnson’s vaccine, and those doses may be available for use overseas.

The United States has already signed a contract to purchase 300 million doses of the Pfizer BioNTech vaccine, which requires two vaccinations to be distributed in the United States; the 500 million cans are on top of that, according to people familiar with the deal.

Biden in Europe

Updated

June 9, 2021, 8:50 p.m. ET

Neither Pfizer nor administrators would tell what the company is charging the government for the cans. Pfizer is also offering the Biden government the option to purchase an additional 200 million cans at cost to be donated overseas.

For Pfizer, the decision to sell so much of the supply to the Biden government for no profit is a significant step.

The vaccine accounted for $ 3.5 billion in sales for the first three months of this year, nearly a quarter of Pfizer’s total sales. By some estimates, the company made approximately $ 900 million in pre-tax income from the vaccine in the first quarter.

However, the company has also been criticized for disproportionately supporting wealthy nations, despite Pfizer’s CEO Albert Bourla promising in January to ensure that “developing countries have equal access to the rest of the world.”

The 200 million Pfizer cans the Biden government plans to donate accounts for about 7 percent of the three billion cans the company is expected to produce this year. Pfizer expects to deliver an additional 800 million doses to lower and lower middle income countries through other agreements with individual countries or Covax, a spokeswoman said.

For Mr Biden, the deal shows that his government is ready to intervene deeper in the treasury to help poorer countries.

Last week, Mr Biden said the United States would be distributing 25 million doses to countries in the Caribbean and Latin America this month; South and Southeast Asia; Africa; and the Palestinian Territories, Gaza and the West Bank.

These cans are the first of 80 million that Mr Biden intended to send abroad by the end of June; three quarters of these are sold by Covax. The rest will be used to address urgent and urgent crises in countries like India, the West Bank and Gaza Strip, government officials said. Many of the 80 million cans were manufactured by AstraZeneca and are still subject to a complex review by the Food and Drug Administration.

Mr Biden has also pledged to support a waiver of an international intellectual property treaty that would make it difficult for companies to refuse their technology. But European leaders are blocking the proposed exemption, and pharmaceutical companies are firmly against it. The World Trade Organization’s Trade-Related Aspects of Intellectual Property Rights Council meets this week to review the derogation.

The president’s promise of vaccines for the world market comes as he prepares on Thursday for a meeting with British Prime Minister Boris Johnson, who has urged leaders to pledge to feed everyone in the world by the end of 2022 vaccinate. Mr Biden’s announcement is likely welcome news to Mr Johnson, whose critics have questioned where the money will come from to keep his promise.

“The truth is, world leaders have been stepping down the street for months – to the point where they ran out of streets,” Edwin Ikhouria, executive director for Africa at ONE Campaign, a nonprofit that dedicated to eradicating global poverty, said in a statement on Wednesday.

About 64 percent of adults in the United States are at least partially vaccinated, and the president’s goal is to increase that number to 70 percent by July 4th, following an accessibility strategy and incentives to reach Americans who have not yet received any injections.

Despite these efforts, there are unused doses of vaccine that could be wasted. Once thawed, cans have a limited shelf life and millions could expire within two weeks, according to federal officials.

Equal access to vaccines has become one of the most persistent challenges in containing the pandemic. Wealthier nations and private corporations have pledged tens of millions of doses and billions of dollars to sustain global supplies, but the disparities in vaccine allocations so far have been stark.

Dr. Tedros Adhanom Ghebreyesus, director general of the World Health Organization, warned this week that the world is facing a “two-pronged pandemic” with countries short of vaccines struggling with virus cases even as better-served countries return to normal.

These lower-income countries will largely depend on wealthier ones until vaccines can be distributed and produced on a more equitable basis, he said.

Daniel E. Slotnik contributed the coverage from New York and Michael D. Shear from Plymouth, England.

Categories
Health

White Home lays out plan to share tens of millions of doses with poorer nations

White House lays out plan to share millions of doses with poorer nations

The Oxford-AstraZeneca covid vaccine.

Karwai Tang | Getty Images

The U.S. government will share the majority of its donated Covid-19 vaccine doses through COVAX, the World Health Organization-led program that provides shots to countries in need, the White House announced Thursday.

The Biden administration has committed to donating at least 20 million doses of Covid vaccines produced by Pfizer-BioNTech, Moderna and Johnson & Johnson as well as 60 million doses of AstraZeneca’s vaccines, which has not yet been authorized for use in the United States.

The U.S. plans to allocate 75% of the vaccines through the COVAX global vaccine sharing program, the White House in an email. Of the first 25 million doses, about 6 million will go to countries in South and Central America, 7 million to Asia and 5 million to Africa, the White House said. About 6 million will go to neighboring countries and U.S. allies.

At least 25% of shots will be kept for immediate U.S. needs and for “countries in need, those experiencing surges, immediate neighbors, and other countries that have requested immediate U.S. assistance,” according to the plan.

The administration is donating the shots to “save lives” and thwart the emergence of new variants,  national security advisor Jake Sullivan said Thursday.

“The United States is not doing this as some kind of back-and-forth deal where we are getting something in return,” Sullivan said at a White House briefing. “We are giving these for a single purpose. It is the purpose of ending this pandemic.”

The announcement comes as world leaders urge wealthy nations such as the U.S. to donate Covid shots to other countries. While the U.S. has returned to some form of normality as more Americans get vaccinated and new cases fall, other countries, like India, have experienced huge outbreaks.

Just last week, the WHO said Africa needed at least 20 million doses of AstraZeneca’s vaccine within six weeks to get the second round of shots to people who have received the first.

The head of the Coalition for Epidemic Preparedness Innovations told Reuters that leaders of the Group of 7 rich nations must donate shots urgently to avoid an outcome akin to the 1918 flu pandemic, which killed 50 million people.

“It’s a moral imperative if we want to avoid situations like Peru, if we want to avoid impacts that could rival those of the 1918 flu, we must send vaccine to countries to protect their health-care workers and protect the vulnerable populations now,” Richard Hatchett, chief executive of CEPI which co-runs the COVAX vaccine sharing facility, told Reuters.

In addition to donating the doses, the White House also announced it is lifting restrictions as part of the Defense Production Act that gave the U.S. priority for vaccines developed by AstraZeneca, Sanofi and Novavax.

Categories
Business

Staff at plant that ruined hundreds of thousands of J&J Covid vaccine doses did not bathe, change garments

Employees at plant that ruined millions of J&J Covid vaccine doses failed to shower, change clothes

Employees work in a laboratory at Emergent Biosolutions in Baltimore, Maryland on February 8, 2021.

Michael Robinson Chavez | The Washington Post | Getty Images

Some employees at the Emergent BioSolutions Baltimore plant were unable to shower or change clothes, which is necessary to work at the factory, and it likely helped ruin millions of Covid-19 cans from Johnson & Johnson’s key committee.

Inspections of the Bayview facility carried out last year also revealed mold problems, poor disinfection of facility equipment and inadequate staff training, employees of the selected coronavirus crisis subcommittee said in the memo. The committee is holding a hearing on Wednesday examining the biopharmaceutical company’s role in the destruction of the J&J recordings.

Although inspectors found poor conditions at the plant, top executives received hundreds of thousands of dollars in bonuses last year and were commended for their leadership by the company’s board of directors. This is evident from other documents published by the committee.

According to one document, aspiring CEO Robert Kramer received a bonus of $ 1.2 million last year, while three other executives received payments of more than $ 400,000.

The U.S. government awarded the company a $ 628 million contract to manufacture coronavirus vaccines last year.

Emergent did not immediately respond to CNBC’s request for comment.

Wednesday’s hearing comes more than a month after the Biden government hired J&J to run the Baltimore plant after US officials learned that Emergent, a federal company that makes key ingredients for J&J and AstraZeneca had produced contaminated contaminated ingredients for the two shots.

During the hearing, Kramer said the FDA is holding over 100 million J&J Covid-19 vaccine doses for further testing.

“There are a significant number of doses that we have manufactured. Here, too, we manufacture the mass drugs,” Kramer told the legislature. “It has been reported by a number of news outlets that there are likely over 100 million doses of the J&J vaccine we make that are now under FDA review for possible release and availability.”

An inspection by the Food and Drug Administration later revealed that the facility was unsanitary and unsuitable for making the shots. In a 13-page report, the inspectors wrote that the facility used to manufacture the vaccine “was not kept in a clean and sanitary condition” and “was not of the appropriate size, design and location for cleaning, maintenance and to facilitate proper operation. “”

FDA inspectors said they observed paint peeling in multiple areas and damaging walls, which could affect “Emergent’s ability to adequately clean and disinfect”. They also found that when handling waste or materials used to make vaccines, employees did not follow standard operating procedures to ensure they were not contaminated.

The facility has not been approved by the FDA to manufacture or distribute Johnson & Johnson’s Covid-19 vaccine, and none of the factory-made doses have been marketed for use in the United States. Emergent has agreed to cease production of materials until the issues identified by the FDA are resolved.

Emergent said at the time it was required to work with the FDA and J&J to resolve the issues.

“While we are never satisfied with defects in our production facilities or processes, these can be corrected and we will take quick action to correct them,” it said in a statement on April 21.

Categories
Business

Mega Hundreds of thousands jackpot is $468 million. Keep away from these blunders in the event you win

Mega Millions jackpot is $468 million. Avoid these blunders if you win

Scott Olson | Getty Images

No, you did not win the Mega Millions jackpot. On the other hand, no one else did either.

The grand prize rose to $ 468 million for Tuesday night’s drawing after no ticket matched all six numbers drawn on Friday night. The amount marks the ninth largest prize in the history of the game.

“That amount is absolutely life changing,” said Walt Blenner, attorney and founder of the Blenner Law Group in Palm Harbor, Florida. “Everything in your life will change and there is no going back.”

Two Mega Millions jackpots were won earlier this year: a $ 1.05 billion win on January 22nd that went to a group of players in Michigan and a $ 96 million prize that went to a New York couple won on February 16.

If you are the next jackpot winner, there are a few mistakes you should avoid to make a smooth transition to extreme wealth.

Oversharing

Blenner recommends sharing the news only with your core family.

“Tell as few people as possible,” he said. “If it gets known, it spreads quickly.”

The ultimate goal should be to protect your identity as much as possible. Some states allow you to claim your award anonymously, while others may allow you to set up a trust or body to claim the money, which will keep your name out of the public eye.

Failure to do so could result in a hurricane of public attention that is not guaranteed to all pass or be innocent.

When representing the winner of a $ 451 million Mega Millions jackpot in 2018, Blenner had to emphasize the importance of disappearing before the public found out who won (in Florida, lottery winners cannot remain anonymous).

They hesitated, so he informed them that ransom and kidnapping insurance was available. That got through to them and they rented a house 20 miles away under a pseudonym.

Hurry to win the prize

I try to do it alone

Before making a claim, you’ll want to assemble a team of seasoned professionals, including a lawyer, accountant, and financial advisor, Blenner said.

“You absolutely need a team around you,” he said.

For example, there may be ways to minimize your tax burden. While 24% of large lottery winnings are withheld for federal taxes, the highest marginal rate of 37% means you would owe a lot more.

For that $ 468 million Mega Millions jackpot, withholding the $ 316.2 million flat option would result in nearly $ 75.9 million being shaved off the top. There are also typically state taxes that may be withheld or due at tax time.

Someone on the team should also serve as the gatekeeper. That means they can answer queries from moochers or scammers, or from anyone else fishing for a piece of your luck.

It’s worth noting that most people never have to worry about these things. The chance that a single ticket will hit all six numbers drawn in Mega Millions is 1 in 302 million. For Powerball – whose jackpot for the Saturday night draw is $ 183 million – your chance of winning the grand prize is a little better: 1 in 292 million.

Categories
World News

Goldman Sachs banker quits after making tens of millions on cryptocurrency

Goldman Sachs banker quits after making millions on cryptocurrency

A collection of Bitcoin, Litecoin, and Ethereum tokens.

Chris Ratcliffe | Bloomberg | Getty Images

LONDON – A Goldman Sachs executive has resigned after making a fortune on a cryptocurrency investment, according to industry reports.

Aziz McMahon, Goldman’s chief executive officer and head of emerging markets sales in London, quit after making millions of pounds on a wager on the digital currency ether, three former investment bank employees told CNBC.

The former employees, who all know McMahon personally, preferred to remain anonymous because of the sensitivity of the discussions. McMahon is believed to have redeemed cryptocurrency worth at least 10 million pounds ($ 14 million).

Previous reports from eFinancial Careers and The Guardian said McMahon left Goldman after making money from Dogecoin.

It is possible that McMahon had some stakes in Dogecoin as well. According to eFinancialCareers, he is now said to have set up his own hedge fund.

When approached by CNBC, Goldman Sachs confirmed McMahon’s departure but declined to comment. McMahon wasn’t immediately available for comment when CNBC contacted him via LinkedIn.

Ether, the digital asset McMahon is said to have invested in, has grown more than 400% since early 2021. Ether was developed about six years after Bitcoin and is based on another technology known as Ethereum. Ether and Ethereum are often used interchangeably to describe the currency.

Bitcoin and other cryptocurrencies have fluctuated a lot lately. On Wednesday, the entire market lost as much as $ 365.85 billion after a tweet from Elon Musk that said his electric car company Tesla would no longer accept bitcoin payments due to environmental concerns about the cryptocurrency.

Musk’s preferred crypto is Dogecoin, a token that started out as a joke in 2013. Inspired by the meme “Doge”, which contains a Shiba-Inu dog and cartoon-style text, Dogecoin was thought of by its creators as a “fun” alternative to Bitcoin.

It has since gained a growing online community and is now the fourth largest digital asset by market value on CoinMarketCap. While proponents like to refer to it as “folk crypto,” investors warn that Dogecoin is a sign of foaming in the crypto market.